Judith Hasko > Latham & Watkins LLP > Silicon Valley, United States > Lawyer Profile
Latham & Watkins LLP Offices
140 SCOTT DRIVE
MENLO PARK
CA 94025
CALIFORNIA
United States
- Firm Profile
- Go to...
Judith Hasko
Position
Judith A. Hasko is a partner in the Corporate Department of Latham & Watkins’ Silicon Valley office and the global Chair of the Life Sciences Licensing Group. Ms. Hasko’s practice focuses on representing companies developing biotechnology, pharmaceutical, medical device and diagnostic products, and investors in such companies, in a wide range of technology-based commercial transactions.
Career
Lawyer Rankings
United States > Intellectual property > Patents: licensing
(Leading lawyers)Latham & Watkins LLP’s global practice is a key destination for life sciences and tech-related IP licensing matters. The solid team handles a broad range of highly complex IP transactions, from cross-licensing and joint development agreements to due diligence and expert review relating to the licensing of IP assets in public offerings and M&A. The practice is spearheaded by California’s Judith Hasko, an expert at negotiating, structuring, and executing cross-border strategic licensing alliances. She is supported by Christopher Hazuka who regularly advises both emerging and established life sciences companies in navigating complex transactions from the Bay Area and San Diego. The team has been strengthened by the recent addition of digital health and food technology expert Jengeun Jekkie Kim, who operates from the firm’s Bay Area office.
United States > Healthcare > Life sciences
(Leading lawyers)Latham & Watkins LLP provides a diverse offering to a number of clients, including biopharmaceutical and biotech start-up companies, and medical device manufacturers. The team advises on a wide range of matters, including white collar investigations, IP disputes, and corporate transactions. Based in California, Shayne Kennedy is particularly adept at advising on public and private securities offerings, and life sciences M&A, while Judith Hasko has a great deal of experience in the execution of strategic licensing alliances, often assisting life sciences companies with securing funding. Arlene Lee Chow works out of the New York office, and routinely acts for biotech and pharmaceutical companies in IP and patent cases. Chicago-based Terra Reynolds is noted for her expertise in government and internal investigations, while the Boston-based Julie Scallen focuses on joint ventures and venture capital transactions within the life sciences and med-tech industries. In Washington DC, John Manthei maintains an FDA regulatory practice with a distinct emphasis on the medical device and biotech industries; Ben Haas has extensive experience in assisting clients with FDA submissions and pre-clinical testing, and Elizabeth Richards often negotiates contracts with clinical trial sites.
United States > Healthcare > Health insurers
Latham & Watkins LLP‘s team combines a strong transactional practice with a focus on complex litigation. John Manthei and Ben Haas co-head the healthcare team from the Washington DC office, while fellow co-head Judith Hasko takes the lead from her base in San Francisco. On the litigation side, Gwyn Williams and David Tolley, both located in Boston, defend major insurers in a series of underpayment claims cases, while Washington DC’s Daniel Meron focuses on False Claims Act matters. Its transactional offering was further strengthened in October 2022 with the arrival of co-chair Jason Caron and Kevin Miller, both formerly at McDermott Will & Emery LLP. Based in Washington DC, Caron leverages clinical and government experience to advise clients on complex healthcare regulatory, reimbursement, and policy matters, while Chicago-based Miller’s practice focuses on advising private equity sponsors and portfolio companies on investment-related transactional healthcare insurance matters.
United States > Healthcare > Service providers
Praised for its ‘excellent’ breadth and depth, Latham & Watkins LLP’s practice assists a diverse roster of financial investors, hospitals, and health systems with FCA and qui tam cases, compliance programs, and the negotiation of corporate integrity agreements. John Manthei and the ‘first class’ Ben Haas co-head the practice from Washington DC, while Judith Hasko co-leads the team from San Francisco. Also based in Washington, Stuart Kurlander often acts for providers before the CMS; and Eric Greig, noted for his ‘energy, commitment and intelligence‘, maintains a strong regulatory focus on issues regarding third party payors. In the San Diego office, Jason Ohta utilizes his experience in white-collar criminal defense to handle healthcare fraud cases. Terra Reynolds supports the team from Chicago, often litigating federal criminal cases.
Lawyer Rankings
- Leading lawyers United States > Healthcare > Life sciences
- Leading lawyers United States > Intellectual property > Patents: licensing
- Life sciences United States > Healthcare
- Patents: licensing United States > Intellectual property
- Service providers United States > Healthcare
- Health insurers United States > Healthcare
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Environment > Environment: transactional
- Environment > Environment: transactional
- Real estate > Land use/zoning
- Real estate > Land use/zoning
- Environment > Environment: transactional
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Real estate > Land use/zoning
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- Environment > Environment: regulatory
- Media, technology and telecoms > Outsourcing
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Environment > Environment: regulatory
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- International Trade > CFIUS
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > Financial services litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Healthcare > Service providers
- Finance > Structured finance: securitization
- International Trade > Customs, export controls and economic sanctions
- Government > Government contracts
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > International arbitration
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)